1.Prescribing rate, healthcare utilization, and expenditure of older adults using potentially inappropriate medications in China: A nationwide cross-sectional study.
Zinan ZHAO ; Mengyuan FU ; Can LI ; Zhiwen GONG ; Ting LI ; Kexin LING ; Huangqianyu LI ; Jianchun LI ; Weihang CAO ; Dongzhe HONG ; Xin HU ; Luwen SHI ; Xiaodong GUAN ; Pengfei JIN
Chinese Medical Journal 2025;138(23):3163-3167
BACKGROUND:
The use of potentially inappropriate medications (PIMs) is a major concern for medication safety as it may entail more harm than potential benefits for older adults. This study aimed to explore the prescribing rate, healthcare utilization, and expenditure of older adults using PIMs in China.
METHODS:
A cross-sectional analysis was conducted using a national representative database of all medical insurance beneficiaries across China, extracting ambulatory visit records of adults aged 65 years and above between 2015 and 2017. Descriptive analysis was conducted to measure the rate of patients exposed to PIM, prescribing rate of each PIM, average annual outpatient visits per patient, average total medication costs for each visit, average annual cost of PIMs for each patient, and average annual medication costs for each patient. Generalized linear model with logit link function and binomial distribution was used to examine the adjusted associations between PIMs and independent variables.
RESULTS:
In total, 845,278 (33.2%) participants were identified to be exposed to at least one PIM. Patients aged 75-84 years (38.1%, 969,809/2,545,430) and ≥85 years (37.9%, 964,718/2,545,430) were more likely to be prescribed with PIMs. Beneficiaries of the Urban Employee Basic Medical Insurance (UEBMI) and living in eastern and southern regions were more frequently prescribed with PIMs. Compared with patients without PIM exposure (7.5 visits, drug cost of RMB 1545.0 Yuan), patients with PIM exposure showed higher adjusted average annual number of outpatient visits (10.7 visits, β = 3.228, 95% confidence interval [CI] = 3.196-3.261) and higher annual drug costs (RMB 2461.8 Yuan, Coef. = 916.864, 95% CI = RMB 906.292-927.436 Yuan).
CONCLUSIONS
The results showed that the use of PIM among older adults was common in China. This study suggests that the use of PIM could be considered as a clear target, pending multidimensional efforts, to promote rational prescribing for older adults.
Humans
;
Aged
;
Cross-Sectional Studies
;
Aged, 80 and over
;
Male
;
Female
;
China
;
Inappropriate Prescribing/economics*
;
Patient Acceptance of Health Care/statistics & numerical data*
;
Potentially Inappropriate Medication List/statistics & numerical data*
;
Health Expenditures/statistics & numerical data*
2.Guideline for Adult Weight Management in China
Weiqing WANG ; Qin WAN ; Jianhua MA ; Guang WANG ; Yufan WANG ; Guixia WANG ; Yongquan SHI ; Tingjun YE ; Xiaoguang SHI ; Jian KUANG ; Bo FENG ; Xiuyan FENG ; Guang NING ; Yiming MU ; Hongyu KUANG ; Xiaoping XING ; Chunli PIAO ; Xingbo CHENG ; Zhifeng CHENG ; Yufang BI ; Yan BI ; Wenshan LYU ; Dalong ZHU ; Cuiyan ZHU ; Wei ZHU ; Fei HUA ; Fei XIANG ; Shuang YAN ; Zilin SUN ; Yadong SUN ; Liqin SUN ; Luying SUN ; Li YAN ; Yanbing LI ; Hong LI ; Shu LI ; Ling LI ; Yiming LI ; Chenzhong LI ; Hua YANG ; Jinkui YANG ; Ling YANG ; Ying YANG ; Tao YANG ; Xiao YANG ; Xinhua XIAO ; Dan WU ; Jinsong KUANG ; Lanjie HE ; Wei GU ; Jie SHEN ; Yongfeng SONG ; Qiao ZHANG ; Hong ZHANG ; Yuwei ZHANG ; Junqing ZHANG ; Xianfeng ZHANG ; Miao ZHANG ; Yifei ZHANG ; Yingli LU ; Hong CHEN ; Li CHEN ; Bing CHEN ; Shihong CHEN ; Guiyan CHEN ; Haibing CHEN ; Lei CHEN ; Yanyan CHEN ; Genben CHEN ; Yikun ZHOU ; Xianghai ZHOU ; Qiang ZHOU ; Jiaqiang ZHOU ; Hongting ZHENG ; Zhongyan SHAN ; Jiajun ZHAO ; Dong ZHAO ; Ji HU ; Jiang HU ; Xinguo HOU ; Bimin SHI ; Tianpei HONG ; Mingxia YUAN ; Weibo XIA ; Xuejiang GU ; Yong XU ; Shuguang PANG ; Tianshu GAO ; Zuhua GAO ; Xiaohui GUO ; Hongyi CAO ; Mingfeng CAO ; Xiaopei CAO ; Jing MA ; Bin LU ; Zhen LIANG ; Jun LIANG ; Min LONG ; Yongde PENG ; Jin LU ; Hongyun LU ; Yan LU ; Chunping ZENG ; Binhong WEN ; Xueyong LOU ; Qingbo GUAN ; Lin LIAO ; Xin LIAO ; Ping XIONG ; Yaoming XUE
Chinese Journal of Endocrinology and Metabolism 2025;41(11):891-907
Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.
3.Research progress in chemical constituents and pharmacological activities of Abelmoschi Corolla and prediction of its quality markers.
Shi-Han GUAN ; Chang LIU ; Xiao-Tong YAN ; Jin-Wei HAN ; Feng-Ting YIN ; Hui SUN ; Guang-Li YAN ; Ling KONG ; Ying HAN ; Xi-Jun WANG
China Journal of Chinese Materia Medica 2025;50(4):908-921
Abelmoschi Corolla, the dried corolla of Abelmoschus manihot, has anti-inflammatory, antioxidant, and anti-fibrosis activities. Its chemical constituents mainly include flavonoids, organic acids, steroids, and polysaccharides. This study reviewed the research progress in the chemical constituents and pharmacological activities of Abelmoschi Corolla in recent 20 years. According to the concept of quality marker(Q-marker), the Q-markers of Abelmoschi Corolla were predicted from plant phylogeny, chemical constituent specificity, traditional efficacy, chemical constituent measurability, and absorbed constituents. The primary Q-markers for Abelmoschi Corolla were anticipated to include quercetin-3'-O-β-D-glucopyranoside, gossypetin-8-O-β-D-glucuronide, isoquercetin, myricetin,quercetin, and hyperoside, with the aim of providing reference data for improving the quality evaluation system of Abelmoschi Corolla.
Abelmoschus/chemistry*
;
Drugs, Chinese Herbal/pharmacology*
;
Flowers/chemistry*
;
Humans
;
Animals
;
Quality Control
;
Flavonoids/chemistry*
4.Guideline for Adult Weight Management in China
Weiqing WANG ; Qin WAN ; Jianhua MA ; Guang WANG ; Yufan WANG ; Guixia WANG ; Yongquan SHI ; Tingjun YE ; Xiaoguang SHI ; Jian KUANG ; Bo FENG ; Xiuyan FENG ; Guang NING ; Yiming MU ; Hongyu KUANG ; Xiaoping XING ; Chunli PIAO ; Xingbo CHENG ; Zhifeng CHENG ; Yufang BI ; Yan BI ; Wenshan LYU ; Dalong ZHU ; Cuiyan ZHU ; Wei ZHU ; Fei HUA ; Fei XIANG ; Shuang YAN ; Zilin SUN ; Yadong SUN ; Liqin SUN ; Luying SUN ; Li YAN ; Yanbing LI ; Hong LI ; Shu LI ; Ling LI ; Yiming LI ; Chenzhong LI ; Hua YANG ; Jinkui YANG ; Ling YANG ; Ying YANG ; Tao YANG ; Xiao YANG ; Xinhua XIAO ; Dan WU ; Jinsong KUANG ; Lanjie HE ; Wei GU ; Jie SHEN ; Yongfeng SONG ; Qiao ZHANG ; Hong ZHANG ; Yuwei ZHANG ; Junqing ZHANG ; Xianfeng ZHANG ; Miao ZHANG ; Yifei ZHANG ; Yingli LU ; Hong CHEN ; Li CHEN ; Bing CHEN ; Shihong CHEN ; Guiyan CHEN ; Haibing CHEN ; Lei CHEN ; Yanyan CHEN ; Genben CHEN ; Yikun ZHOU ; Xianghai ZHOU ; Qiang ZHOU ; Jiaqiang ZHOU ; Hongting ZHENG ; Zhongyan SHAN ; Jiajun ZHAO ; Dong ZHAO ; Ji HU ; Jiang HU ; Xinguo HOU ; Bimin SHI ; Tianpei HONG ; Mingxia YUAN ; Weibo XIA ; Xuejiang GU ; Yong XU ; Shuguang PANG ; Tianshu GAO ; Zuhua GAO ; Xiaohui GUO ; Hongyi CAO ; Mingfeng CAO ; Xiaopei CAO ; Jing MA ; Bin LU ; Zhen LIANG ; Jun LIANG ; Min LONG ; Yongde PENG ; Jin LU ; Hongyun LU ; Yan LU ; Chunping ZENG ; Binhong WEN ; Xueyong LOU ; Qingbo GUAN ; Lin LIAO ; Xin LIAO ; Ping XIONG ; Yaoming XUE
Chinese Journal of Endocrinology and Metabolism 2025;41(11):891-907
Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.
5.Identification and expression analysis of cellulose synthase family genes in Aquilaria sinensis
Xin-yu MI ; Hai-ling QIU ; Fan-yuan GUAN ; Yu-yan ZHENG ; Xiao-hui WANG ; She-po SHI
Acta Pharmaceutica Sinica 2024;59(1):253-264
Cellulose synthase (CesA), one of the key enzymes in the biosynthesis of cellulose in plants, plays an important role in plant growth and plant resistance. In this study, a total of 21
6.Construction and evaluation of a predictive model for recurrence of intrahepatic bile duct stones after surgery
Bin WANG ; Gao-chao JIN ; Pei GUAN ; Ling-xin KONG ; Jia SHI
Chinese Journal of Current Advances in General Surgery 2024;27(11):861-866
Objective:To construct and evaluate a predictive model for the recurrence of hepatolithiasis after surgery based on clinical data and serum retinol binding protein 4 (RBP4) and cholecystokinin A (CCK-A). Methods:One hundred and thirty-five patients with intrahepatic duct stone who underwent laparoscopic combined choledochoscopic lithotripsy admitted to our hospital from January 2020 to December 2022 were retrospectively included and divided into a modeling set (n=90) and a validation set (n=45) according to a 2:1 ratio. Patients were divided into relapse group and non-recurrence group according to recurrence status within 1-year follow-up. Univari-ate Logistic regression analysis was performed to analyze the influencing factors of postoperative recurrence of patients. A nomogram was constructed according to the influencing factors,and cali-bration curve,consistency index,receiver operating characteristic curve (ROC) and decision curve were used for internal and external verification. Results:In the modeling set,patients with bilat-eral stone distribution,maximum stone diameter ≥10 mm,bile duct stenosis,multiple stone num-bers,and paracystic diverticulum in the recurrent group had higher serum levels of RBP4 than those in the non-recurrent group at 7 days after surgery,and lower serum levels of CCK-A than those in the non-recurrent group at 7 days after surgery (P<0.05). The factors of recurrence after hepatoli-thiasis surgery were the maximum stone diameter ≥10 mm,bilateral stone distribution,bile duct stenosis,multiple stone numbers,paracystic diverticulum,serum RBP4 level 7 days after surgery,and serum CCK-A level 7 days after surgery (P<0.05). A nomogram was constructed based on the influencing factors,and internal and external validation showed that the prediction model had good predictive ability and clinical net benefit. Conclusion:The influencing factors of recurrence after hepatolithiasis surgery include serum RBP4 levels 7 days after surgery and bilateral stone distribu-tion. The nomogram prediction model constructed based on these factors has high predictive value and clinical benefit.
7.Construction and evaluation of a predictive model for recurrence of intrahepatic bile duct stones after surgery
Bin WANG ; Gao-chao JIN ; Pei GUAN ; Ling-xin KONG ; Jia SHI
Chinese Journal of Current Advances in General Surgery 2024;27(11):861-866
Objective:To construct and evaluate a predictive model for the recurrence of hepatolithiasis after surgery based on clinical data and serum retinol binding protein 4 (RBP4) and cholecystokinin A (CCK-A). Methods:One hundred and thirty-five patients with intrahepatic duct stone who underwent laparoscopic combined choledochoscopic lithotripsy admitted to our hospital from January 2020 to December 2022 were retrospectively included and divided into a modeling set (n=90) and a validation set (n=45) according to a 2:1 ratio. Patients were divided into relapse group and non-recurrence group according to recurrence status within 1-year follow-up. Univari-ate Logistic regression analysis was performed to analyze the influencing factors of postoperative recurrence of patients. A nomogram was constructed according to the influencing factors,and cali-bration curve,consistency index,receiver operating characteristic curve (ROC) and decision curve were used for internal and external verification. Results:In the modeling set,patients with bilat-eral stone distribution,maximum stone diameter ≥10 mm,bile duct stenosis,multiple stone num-bers,and paracystic diverticulum in the recurrent group had higher serum levels of RBP4 than those in the non-recurrent group at 7 days after surgery,and lower serum levels of CCK-A than those in the non-recurrent group at 7 days after surgery (P<0.05). The factors of recurrence after hepatoli-thiasis surgery were the maximum stone diameter ≥10 mm,bilateral stone distribution,bile duct stenosis,multiple stone numbers,paracystic diverticulum,serum RBP4 level 7 days after surgery,and serum CCK-A level 7 days after surgery (P<0.05). A nomogram was constructed based on the influencing factors,and internal and external validation showed that the prediction model had good predictive ability and clinical net benefit. Conclusion:The influencing factors of recurrence after hepatolithiasis surgery include serum RBP4 levels 7 days after surgery and bilateral stone distribu-tion. The nomogram prediction model constructed based on these factors has high predictive value and clinical benefit.
8. Artesunate inhibits development of breast cancer cells via affecting expression of Skp2 and CDKN1A
Li-Ting SUN ; Guan-Tong SHEN ; Fei ZHU ; Jing KANG ; Jing YUE ; Ru-Yi SHI ; Xiao-Ling HU ; Nan QIN ; Ke LIAN ; Jing KANG ; Jing YUE
Chinese Pharmacological Bulletin 2023;39(9):1675-1681
Aim To explore the effect of artesunate (ART) on the function of breast cancer cells during the progression of breast cancer and the possible mechanism of action. Methods MCF-7 (30 μmol • L-
9. Artesunate inhibits development of esophageal squamous cell carcinoma via regulating expression of Skp2 and P21
Min ZHANG ; Li-Ting SUN ; Guan-Tong SHEN ; Ru-Yi SHI ; Min ZHANG ; Ru-Yi SHI ; Nan QIN ; Xiao-Ling HU ; Jie YANG ; Yong-Hua ZHANG
Chinese Pharmacological Bulletin 2023;39(5):844-850
Aim To clarify the regulatory effect of Artesunate(ART) on tumor cell function and cell cycle in the pathological process of esophageal squamous cell carcinoma(ESCC). Methods KYSE450 and TE14 cells were treated with different concentrations of ART. The cells treated with 0 mg •L
10.Comparative analysis of domestic classification management list for clinical use of antibiotics versus WHO AWaRe classification list of antibiotics
Yaoyao YANG ; Kexin LING ; Xi ZHANG ; Kexin DU ; Wanmeng ZHANG ; Lin HU ; Bo ZHENG ; Xiaodong GUAN ; Wushouer HAISHAERJIANG ; Luwen SHI
China Pharmacy 2022;33(24):2945-2951
OBJECTIVE To provide reference and suggestions for dynamic adjustment of classification management lists for clinical use of antibiotics and the promotion of rational use of antibiotics. METHODS The latest version of provincial classification management lists for clinical use of antibiotics were aggregated into the “national list”, which was compared with 2021 WHO AWaRe classification list of antibiotics (hereinafter referred as to “AWaRe classification list”) to make a descriptive statistical analysis about the number of different classes of antibiotics in the two lists and their differences. RESULTS Based on the different classification principles, 262 kinds of antibiotic preparations in the national list were classified into non-restricted (84), restricted (83) and highly-restricted classes (95), and 258 kinds in the AWaRe classification list were classified into access (87), watch (142) and reserve classes (29); 182 kinds of antibiotic preparations were both included in the two lists. In the national list, among the non-restricted antibiotic preparations, 36 kinds belonged to access class, 30 belonged to watch class and 1 belonged to reserve class; among restricted antibiotic preparations, 7 belonged to access class, 46 kinds belonged to watch class and 3 belonged to reserve class; among highly-restricted antibiotic 82805019。E-mail:yyy211anne@163.com preparations, 9 belonged to access class, 35 belonged to watch class and 15 kinds belonged to reserve class. Among them, 91 kinds of antibiotic preparations were not recommended by WHO (20 kinds) or not included in the AWaRe classification list (71 kinds). CONCLUSIONS The classification methods of two lists are different in classification principles and grading of some similar drugs. The classification management list of antibiotics is one of the key points of antibiotics management, more research is needed in the future to provide sufficient evidence for optimizing antibiotics classification management.

Result Analysis
Print
Save
E-mail